1,927 results on '"Crowe, James E."'
Search Results
102. Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics
103. Crowdsourcing Immunity
104. Croup
105. Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth
106. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
107. Enterovirus D68 in the Anterior Horn Cells of a Child with Acute Flaccid Myelitis
108. Computational epitope mapping of class I fusion proteins using Bayes classification
109. Human Monoclonal Antibodies to Escherichia coli Outer Membrane Protein A Porin Domain Cause Aggregation but Do Not Alter In Vivo Bacterial Burdens in a Murine Sepsis Model
110. Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region
111. The human antibody sequence space and structural design of the V, J regions, and CDRH3 with Rosetta
112. Structural mapping of antibody landscapes to human betacoronavirus spike proteins
113. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
114. Human Antibodies for Viral Infections
115. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
116. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity
117. The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
118. Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking
119. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique
120. Antibody Responses and Functions in Defense against Viral Infection
121. Reply to Schlapbach et al
122. 115 - Host Defense Mechanisms Against Viruses
123. Population-Based Incidence of Human Metapneumovirus Infection among Hospitalized Children
124. Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus
125. Respiratory Syncytial Virus Uses a Vps4-Independent Budding Mechanism Controlled by Rab11-FIP2
126. Genetic Basis for Adverse Events after Smallpox Vaccination
127. Genetic Predisposition for Adverse Events after Vaccination
128. Bispecific antiviral neutralizing antibodies are twice as nice
129. Even old foes can learn sweet new tricks
130. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
131. Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
132. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
133. Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
134. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection
135. Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
136. Cellular Immune Responses to Diluted and Undiluted Aventis Pasteur Smallpox Vaccine
137. Cytokine Expression Patterns Associated with Systemic Adverse Events following Smallpox Immunization
138. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
139. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies
140. Neutralization Fingerprinting Technology for Characterizing Polyclonal Antibody Responses to Dengue Vaccines
141. The Role of Human Metapneumovirus in Upper Respiratory Tract Infections in Children: A 20-Year Experience
142. Human Metapneumovirus Infection Plays an Etiologic Role in Acute Asthma Exacerbations Requiring Hospitalization in Adults
143. A Prospective Study Comparing Human Metapneumovirus with Other Respiratory Viruses in Adults , with Hematologic Malignancies and Respiratory Tract Infections
144. Proof of principle for epitope-focused vaccine design
145. Prevalence of Reovirus-Specific Antibodies in Young Children in Nashville, Tennessee
146. Smallpox Vaccination Does Not Elevate Systemic Levels of Prothrombotic Proteins Associated with Ischemic Cardiac Events
147. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations
148. Committing the Oldest Sins in the Newest Kind of Ways-Antibodies Targeting the Influenza Virus Type A Hemagglutinin Globular Head
149. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
150. Adverse Events after Smallpox Immunizations Are Associated with Alterations in Systemic Cytokine Levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.